Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) LONDON, ONTARIO - TheNewswire - November 30, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF ) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr. Piotr Witkowski, principal investigator...
(TheNewswire) - 5 of 7 study patients implanted with Cell Pouch and cell transplants ongoing; full enrollment on track for early 2021 - Treated patients continue to demonstrate enduring safety indicators and blood levels of insulin (C-peptide) p...
(TheNewswire) L ondon, Ontario - TheNewswire - October 30, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, announces that, subject to acceptance by the TSX Venture Exchange, it intends to ex...
(TheNewswire) LONDON, ONTARIO - TheNewswire - October 29, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, was invited by the TMX Group to present today at the first-ever TSX Life Sciences Investor D...
(TheNewswire) Sernova Retains Integral Wealth Securities for Market Making Services October 27, 2020 9:00 a.m. EDT LONDON, ONTARIO - TheNewswire - October 27, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) , a clinical-stage regen...
(TheNewswire) Sernova to deliver corporate update with focus on value-driving events: technology acquisition, licensing and research collaboration LONDON, ONTARIO - TheNewswire - September 24, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:P...
(TheNewswire) LONDON, ONTARIO - TheNewswire - September 23, 2020 - Sernova Corp. ("Sernova" or the "Company") (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) is pleased to announce that it has closed its non-brokered private placement announced on Septembe...
(via TheNewswire) Sernova to also present Corporate Update as part of Company Presentations L ondon, Ontario - TheNewswire - September 10, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, announced today th...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - September 9, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) , a clinical-stage regenerative medicine therapeutics company, is pleased to announce that the Company has secured a $2 million lead order in connecti...
(via TheNewswire) Sernova expands its intellectual property portfolio and capabilities to develop first-in-class cell therapy solutions for type 1 diabetes and other chronic diseases that eliminate the need for life-long immunosuppression drugs LONDON, ONTARIO - Augus...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...